(10) Palliative care

Pharmaceutical Journal

Volumn 265, Issue 7119, 2000, Pages 603-614

  Urie, Jane ^b   Fielding, Helen ^a   McArthur, Dorothy ^a   Kinnear, Moira ^b   Hudson, Steve ^b   Fallon, Marie ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; ANTIEMETIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; DIAMORPHINE; LAXATIVE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; TRICYCLIC ANTIDEPRESSANT AGENT;

ANALGESIA; CANCER PATIENT; PALLIATIVE THERAPY; PATIENT CARE; QUALITY OF LIFE; REVIEW;

EID: 0034699815     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. McCarthy M, Addington-Hall JM. Dying from heart disease. J R Coll Physicians 1996;30:325-8.
2. Skilbeck J, Mott L, Page H, Smith D, Hjelmeland-Ahmedzai S, Clark D. Palliative care in chronic obstructive airways disease: a needs assessment. Palliative Med 1998;12:245-54.
3. Grond S, Zech D, Diefenbach C, Bischoff A. Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1,635 cancer patients referred to a pain clinic. J Pain Symptom Manage 1994;9:372-82.
4. Curtis EB, Krech R, Walsh TD. Common symptoms in patients with advanced cancer. J Palliative Care 1991;7:25-9.
5. WHO guidelines: Cancer pain relief. 2nd ed. Geneva: World Health Organisation; 1996.
6. Cancer Research Campaign. About cancer: statistics. Cancer Research Campaign; 2000.
7. Addington-Hall JM, McCarthy M. Dying from cancer: results of a national population-based investigation. Palliative Med 1995;9:295-305.
8. Eastaugh AW. Approaches to palliative care by primary health care teams: a survey. J Palliative Care 1996;12:47-50.
9. Jarret N, Payne S, Turner P, Hillier R. "Someone to talk to" and "pain control": what people expect from a specialist palliative care team. Palliative Med 1999;13:139-44.
10. Parkes CM. Bereavement. In: Doyle D, Hanks GWC, MacDonald N, editors. Oxford textbook of palliative medicine. 2nd ed. Oxford: Oxford Medical Publications; 1998, p995-1010.
11. Specialist palliative care: A statement of definitions. London: National Council for Hospice and Specialist Palliative Care Services; 1995.
12. Cummings I. The interdisciplinary team. In: Doyle D, Hanks GWC, MacDonald N, editors. Oxford textbook of palliative medicine. 2nd ed. Oxford: Oxford Medical Publications; 1998, p19-30.
13. Sykes NP, Pearson SE, Chell S. Quality of care of the terminally ill: the carer's perspective. Palliative Med 1992;6:227-36.
14. Patient held records in palliative and cancer care. Practical proposition or pie in the sky? In: Scottish Partnership Agency for Palliative and Cancer Care and National Council for Hospice and Specialist Palliative Care Services. Newcastle; 1998.
15. Donnelly S, Walsh D. The symptoms of advanced cancer. Semin Oncol 1995;22:67-72.
16. Cherny N, Sapir R, Catane R, Kaufman B, Isacson R, Segal R, et al. Symptom prevalence and severity among ambulatory patients attending an integrated oncology-palliative care day hospital. Proceedings of the Annual Meeting of the American Society of Clinical Oncology 1999;18:A2247.
17. Vainio A, Auvunen A and members of the symptom prevalence group. Prevalence of symptoms among patients with advanced cancer: an international collaborative study. J Pain Symptom Manage 1996;12:3-10.
18. Wachtel T, Allen-Masterton S, Reuben D, Goldberg R, Mor V. The end stage cancer patient: terminal common pathway. Hospice J 1988;4:43-80.
19. Conill C, Verger E, Henriquez I, Saiz N, Espier M, Lugo F, et al. Symptom prevalence in the last week of life. J Pain Symptom Manage 1997;14:328-31.
20. Chochinov HM, Tataryn D, Clinch JJ, Dudgeon D. Will to live in the terminally ill. Lancet 1999;354:816-9.
21. Baines MJ. ABC of palliative care. Nausea, vomiting and intestinal obstruction. BMJ 1997;315:1148-50.
22. Zech D, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organisation guidelines for cancer pain relief: a 10 year prospective study. Pain 1995;63:65-76.
23. Davis CL. ABC of palliative care. Breathlessness, cough and other respiratory problems. BMJ 1997;315:931-4.
24. O'Boyle CA, Moriarty MJ, Hillard N. Clinical and psychological aspects of cancer related pain. Irish Psychol Med 1988;5:89-92.
25. Sykes NP. The relationship between opioid use and laxative use in terminally ill cancer patients. Palliative Med 1998;12:375-82.
26. Rinck GC, van den Bos GAM, Kleijnen J, de Haes HJCJM, Schade E, Veenhof CHN. Methodologic issues in effectiveness research on palliative cancer care: a systematic review. J Clin Oncol 1997;15:1697-707.
27. Control of pain in patients with cancer. Edinburgh: Scottish Intercollegiate Guidelines Network, Scottish Cancer Therapy Network; June, 2000.
28. McQuay H, Moore A. Bibliography and systematic reviews in cancer pain. A report to the NHS National Cancer Research and Development Programme. Oxford: National Health Service; 1997.
29. Twycross R, Back I. Nausea and vomiting in advanced cancer. Eur J Palliative Care 1998;5:39-44.
30. Quidling H, Persson G, Ahlstrom U, Baugens S, Hellem S, Johansson G, et al. Paracetamol plus supplementary doses of codeine. An analgesic study of repeated doses. Eur J Clin Pharmacol 1982;23:315-9.
31. Expert Working Group of the European Association for Palliative Care. Morphine in cancer pain: modes of administration. BMJ 1996;312:823-6.
32. Fallon MT, Hanks GWC. Opioid resistant pain in cancer: sense or nonsense? Pain Clin 1993;6:205-6.
33. Gillette J, Ferme C, Gehanno P, Mignot L, Schach R, Vignaux J, et al. Double blind cross-over clinical and pharmacokinetic comparison of oral morphine syrup and sustained release morphine capsules in patients with cancer related pain. Clin Drug Invest 1997;Suppl:1-6.
34. Hoskin P, Poulain P, Hanks GWC. Controlled release morphine in cancer pain. Is a loading dose required when the formulation is changed? Anaesthesia 1989;44:897-901.
35. Sykes NP. A volunteer model for the comparison of laxatives in opioid-related constipation. J Pain Symptom Manage 1996;11:363-9.
36. McIllmurray MB, Warren MR. Evaluation of a new hospice: the relief of symptoms in cancer patients in the first year. Palliative Med 1989;3:135-40.
37. Moulin DE, Johnson NG, Murray-Parsons N, Geoghegan MF, Goodwin VA, Chester MA. Subcutaneous narcotic infusions for cancer pain: treatment outcome and guidelines for use. Can Med Assoc J 1992;146:891-7.
38. Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy and quality of life. J Pain Symptom Manage 1997;13:254-61.
39. Moriarty M, McDonald IJ, Miller AJ. Randomised cross over comparison of controlled release morphine tablets in patients with cancer pain. J Clin Res 1999;2:1-8.
40. Heiskanen T, Kalso E. Controlled-release oxycodone and morphine in cancer related pain. Pain 1997;73:37-45.
41. The management of metastatic bone disease in the United Kingdom. The Breast Speciality Group of the British Association of Surgical Oncology. Eur J Surgical Oncol 1999;25:3-23.
42. Plummer JL, Cherry DA, Cousins MJ, Gourlay GK, Onley MM, Evans KH. Long-term spinal administration of morphine in cancer and non-cancer pain: a retrospective study. Pain 1991;44:215-20.
43. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Pain 1986;Suppl 3:1-226.
44. Levin D, Cleeland CS. Public attitudes towards cancer pain. Cancer 1985;56:2337-9.
45. Levin ML, Berry JI, Leiter J. Management of pain in terminally ill patients: physician reports of knowledge, attitudes and behaviour. J Pain Symptom Manage 1998;15:27-40.
46. McCaffery M. Nursing management of the patient in pain. Philadelphia: JB Lippincott; 1972.
47. Nekolaichuk CL, Bruera E, Spachynski K, MacEachern T, Hanson J, Maguire TO. A comparison of patient and proxy symptom assessments in advanced cancer patients. Palliative Med 1999;13:311-23.
48. Higginson I, Wade A, McCarthy M. Palliative care: views of patients and their families. BMJ 1990;300:277-81.
49. Twycross R, Lack SA. Symptom control in advanced cancer. London: Pitman Books Ltd; 1984.
50. Grond S, Zech D, Diefenbach C, Radbruch L, Lehmann KA. Assessment of cancer pain: a prospective evaluation in 2,266 cancer patients referred to a pain service. Pain 1996;64:107-14.
51. Mercadante S, Armata M, Salvaggio L. Pain characteristics of advanced lung cancer patients referred to a palliative care service. Pain 1994;59:141-5.
52. Dellemijn PL, Vanneste JA. Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyi in neuropathic pain. Lancet 1997;349:753-8.
53. O'Neill B, Fallon MT, ABC of palliative care. Principles of palliative care and pain control. BMJ 1997;315:801-4.
54. Hawley P, Forbes K, Hanks GWC. Opioids, confusion and opioid rotation. Palliative Med 1998;12:63-4.
55. Fallon MT. Opioid rotation: does it have a role? Palliative Med 1997;11:177-8.
56. Clarke EB, French B, Bilodeau ML, Capasso VC, Edwards A, Empoliti J. Pain management knowledge, attitudes and clinical practice: the impact of nurses' characteristics and education. J Pain Symptom Manage 1996;11:18-31.
57. Fallon MT, de Williams AC, Hanks GWC, Ghodse H. Why don't patients with pain become addicted to morphine? Proceedings of 8th World Conference on Pain: IASP; 1997. p390.
58. Fallon MT, Hanks GWC. Do patients who have received intravenous opioids post-bone marrow transplant develop physical dependence? Proceedings of 5th Conference EAPC; London: 1997. pP127.
59. Foley KM. Pharmacological approaches to cancer pain management. In: Fields H, editor. Advances in pain research and therapy. New York: Raven; 1989. p629-53.
60. Mantovani G, Maccio A, Lai P, Massa E, Ghiani M, Santona MC. Cytokine involvement in cancer anorexia/ cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms. Crit Rev Oncogenesis 1998;9:99-106.
61. Bruera E. ABC of palliative care. Anorexia, cachexia, and nutrition. BMJ 1997;315:1219-22.
62. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, Krook JE, Wilwerding MB, et al. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymestrone for the treatment of cancer anorexia/cachexia. J Clin Oncol 1999;17:3299-306.
63. Vadell C, Segui MA, Gimenez-Arnau JM, Morales S, Cirera L, Bestit I, et al. Anticachetic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia. Am J Clin Oncol 1998;21:347-51.
64. Dunlop GM. A study of the relative frequency and importance of gastrointestinal symptoms and weakness in patients with far advanced cancer. Palliative Med 1989;4:37-43.
65. Mannix KA. Palliation of nausea and vomiting. In: Doyle D, Hanks GWC, MacDonald N, editors. Oxford textbook of palliative medicine. 2nd ed. Oxford: Oxford Medical Publications; 1998. p489-99.
66. Fallon M, O'Neill B. ABC of palliative care: Constipation and diarrhoea. BMJ 1997;315:1293-6.
67. Heyse-Moore L, Beynon T, Ross V. Does spirometery predict dyspnoea in advanced cancer? Palliative Med 2000;14:189-95.
68. Dudgeon DJ, Lertzman M. Dyspnoea in the advanced cancer patient. J Pain Symptom Manage 1998;16:212-9.
69. Bruera E, de Stoutz ND, Velasco-Leiva A, Schoeller T, Hanson J. Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patients. Lancet 1993;342:13-4.
70. Twycross R, Lichter I. The terminal phase. In: Doyle D, Hanks GWC, MacDonald N, editors. Oxford textbook of palliative medicine. 2nd ed. Oxford: Oxford Medical Publications; 1998. p977-92
71. Adam J. ABC of palliative care. The last 48 hours. BMJ 1997;315:1600-3.
72. Ethical decision making. Artificial hydration (AH) for people who are terminally ill. Eur J Palliative Care 1997;4:124.
73. Fainsinger R, MacEachern T, Miller MJ, Bruera E, Spachynski K, Kuehn N, et al. The use of hypodermoclysis for rehydration in terminally ill cancer patients. J Pain Symptom Manage 1994;95:298-302.
74. Philip J, Smith WB, Craft P, Lickiss N. Concurrent validity of the modified Edmonton Symptom Assessment System with the Rotterdam Symptom Checklist and the Brief Pain Inventory. Supportive Care Cancer 1998;6:539-41.
75. Spiller JA, Alexander DA. Domiciliary care: a comparison of the views of terminally ill patients and their family caregivers. Palliative Med 1993;7:109-15.
76. Field D, Douglas C, Jagger C, Dand P. Terminal illness: views of patients and their lay carers. Palliative Med 1995;9:45-54.
77. Zeppetella G. How do terminally ill patients at home take their medication? Palliative Med 1999;13:469-75.
78. Home R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999;47:555-67.
79. Speirs MV, Kutzik DM. Self-reported memory of medication use by the elderly. Am J Health Syst Pharm 1995;52:985-90.
80. Allen M, Jenkins T. Avoiding the hunt for medicines. Pharm J 1996;257:234.
81. Cousins DH, Upton DR. Make infusion pumps safer to use. Pharm Pract 1995;5:401-6.
82. Atkinson CV, Kirkham SR. Unlicensed uses for medication in a palliative care unit. Palliative Med 1999;13:145-52.
83. Morrow N, Hargie O, Woodman C. Consumer perceptions of and attitudes to the advice-giving role of community pharmacists. Pharm J 1993;251:25-7.
84. Morrow N, Hargie O, Donnelly H, Woodman C. "Why do you ask?" A study of questioning behaviour in community pharmacist-client consultations. Int J Pharm Pract 1993;2:90-4.
85. Grande GE, Todd CJ, S.I.G. B. Support needs in the last year of life: patient and carer dilemmas. Palliative Med 1997;11:202-8.
86. Haynes RB, Wang E, De Mota Gomes M. A critical review of interventions to improve compliance with prescribed medications. Patient Educ Counselling 1987;10:155-66.
87. Lucas C, Glare PA, Sykes JV. Contribution of a liaison pharmacist to an inpatient palliative care unit, Palliative Med 1997;11:209-16.